The FDA-approved Gold Drug Auranofin Inhibits Novel Coronavirus (SARS-COV-2) Replication and Attenuates Inflammation in Human Cells

doi 10.1101/2020.04.14.041228
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Cold Spring Harbor Laboratory

Related search

FDA Approved Drugs With Broad Anti-Coronaviral Activity Inhibit SARS-CoV-2 in Vitro

2020English

Insights Into the Recent 2019 Novel Coronavirus (SARS-CoV-2) in Light of Past Human Coronavirus Outbreaks

Pathogens
ImmunologyMolecular BiologyAllergyMicrobiologyMicrobiology Infectious Diseases
2020English

The Emergence of a Novel Coronavirus (SARS-CoV-2), Their Biology and Therapeutic Options

Journal of Clinical Microbiology
Microbiology
2020English

Novel Coronavirus (SARS-CoV-2) Infection in a Renal Transplant Recipient: Case Report

American Journal of Transplantation
TransplantationAllergyImmunologyPharmacology
2020English

Antibody Responses to SARS-CoV-2 in Patients of Novel Coronavirus Disease 2019

2020English

Comparative Genomic Analysis Revealed Specific Mutation Pattern Between Human Coronavirus SARS-CoV-2 and Bat-SARSr-CoV RaTG13

2020English

Genome-Wide Data Inferring the Evolution and Population Demography of the Novel Pneumonia Coronavirus (SARS-CoV-2)

2020English

Deducing the N- And O- Glycosylation Profile of the Spike Protein of Novel Coronavirus SARS-CoV-2

2020English

RT‐LAMP for Rapid Diagnosis of Coronavirus SARS‐CoV‐2

Microbial Biotechnology
Applied MicrobiologyBiotechnologyBiochemistryBioengineering
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy